Alerts will be sent to your verified email
Verify EmailAVIENCE
|
Avience Biomedicals
|
Morepen Laboratories
|
|
|---|---|---|
|
Operational Metrics
|
||
|
Financials
|
||
|
5 yr Average ROE
|
28.55 % | 13.43 % |
|
5yr average Equity Multiplier
|
3.49 | 1.68 |
|
5yr Average Asset Turnover Ratio
|
0.86 | 1.29 |
|
5yr Avg Net Profit Margin
|
10.76 % | 5.93 % |
|
Price to Book
|
n/a | 2.29 |
|
P/E
|
n/a | 30.07 |
|
5yr Avg Cash Conversion Cycle
|
118.39 Days | 12.78 Days |
|
Inventory Days
|
125.1 Days | 54.64 Days |
|
Days Receivable
|
102.08 Days | 65.45 Days |
|
Days Payable
|
83.86 Days | 96.29 Days |
|
5yr Average Interest Coverage Ratio
|
5.5 | 39.11 |
|
5yr Avg ROCE
|
30.48 % | 15.77 % |
|
5yr Avg Operating Profit Margin
|
18.5 % | 8.68 % |
|
5 yr average Debt to Equity
|
1.35 | 0.04 |
|
5yr CAGR Net Profit
|
56.36 % | 3.98 % |
|
5yr Average Return on Assets
|
8.99 % | 7.67 % |
|
Shareholdings
|
||
|
Promoter Holding
|
n/a | 35.65 % |
|
Share Pledged by Promoters
|
n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
n/a | -2.57 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 |
|
Avience Biomedicals
|
Morepen Laboratories
|
|
|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Customer Wise Break-Up
|
Customer Wise Break-Up
|
-
|